Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
mi
from
Tulsa, OK
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
mi
from
Hampton, VA
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
mi
from
Hampton, VA
Click here to add this to my saved trials
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated:  12/31/1969
Pfizer Investigational Site
mi
from
Montreal,
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
mi
from
Montreal,
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Usc Crs
mi
from
Los Angeles, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Usc Crs
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Ucsd, Avrc Crs
mi
from
San Diego, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Ucsd, Avrc Crs
mi
from
San Diego, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
University of Minnesota, ACTU
mi
from
Minneapolis, MN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Minnesota, ACTU
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Cornell CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Cornell CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
HIV Prevention & Treatment CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
HIV Prevention & Treatment CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Trillium Health ACTG CRS
mi
from
Rochester, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Trillium Health ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Unc Aids Crs
mi
from
Chapel Hill, NC
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Unc Aids Crs
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Case CRS
mi
from
Cleveland, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Case CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Pitt CRS
mi
from
Pittsburgh, PA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Pitt CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Therapeutics CRS
mi
from
Nashville, TN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Therapeutics CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Puerto Rico AIDS CRS
mi
from
San Juan,
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Puerto Rico AIDS CRS
mi
from
San Juan,
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Ucsf Aids Crs
mi
from
San Francisco, CA
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Ucsf Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Washington U CRS
mi
from
Saint Louis, MO
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Washington U CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Cornell CRS
mi
from
New York, NY
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Cornell CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Harlem ACTG CRS
mi
from
New York, NY
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Harlem ACTG CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Unc Aids Crs
mi
from
Chapel Hill, NC
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Unc Aids Crs
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated:  12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens
Status: Enrolling
Updated: 12/31/1969
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials